NCT04142983View on ClinicalTrials.gov

Tdap Vaccine Safety for Plasma Donors

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

November 3, 2021

Study Completion Date

November 16, 2021

Conditions
Tetanus
Interventions
BIOLOGICAL

Adacel

0.5 mL, Intramuscular

Trial Locations (2)

78040

GCAM Laredo Center, Laredo

78852

GCAM Eagle Pass Center, Eagle Pass

Sponsors

Lead Sponsor

GCAM Inc.
All Listed Sponsors
lead

GCAM Inc.

INDUSTRY

NCT04142983 - Tdap Vaccine Safety for Plasma Donors | Biotech Hunter | Biotech Hunter